Blood Neoplasia Oncology

Post-transplant outcomes after intensive chemotherapy versus hypomethylating agent/venetoclax in acute myeloid leukemia

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →